Hansoh Pharmaceutical Group Company Limited 

0
13
+$0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

財報

8月26日預期
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0.03
0.06
0.08
0.1
預期EPS
0.0721182
實際EPS
0.103026

財務

36.91%利潤率
有盈利
2020
2021
2022
2023
2024
2025
2.12B營收
783.6M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 HNPHY 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
顯示更多
執行長
Hui Juan Zhong
員工
9643
國家
開曼群島
ISIN
US4109081079

上市

0 則留言

分享你的想法

常見問題

Hansoh Pharmaceutical Group Company Limited 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Hansoh Pharmaceutical Group Company Limited 的股票以代號 HNPHY 進行交易。
Hansoh Pharmaceutical Group Company Limited 下一次財報日期是什麼時候?▼
Hansoh Pharmaceutical Group Company Limited 將於 2027年3月30日 公布下一次財報。
Hansoh Pharmaceutical Group Company Limited 上一季度的財報如何?▼
HNPHY 上一季度的財報為每股 0.1 USD,預估為 0.07 USD,帶來 +42.86% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Hansoh Pharmaceutical Group Company Limited 去年的營收是多少?▼
Hansoh Pharmaceutical Group Company Limited 去年的營收為 2.12BUSD。
Hansoh Pharmaceutical Group Company Limited 去年的淨利是多少?▼
HNPHY 去年的淨收益為 783.6MUSD。
Hansoh Pharmaceutical Group Company Limited 有多少名員工?▼
截至 2026年11月17日,公司共有 9,643 名員工。
Hansoh Pharmaceutical Group Company Limited 位於哪個產業?▼
Hansoh Pharmaceutical Group Company Limited從事於Health & Wellness產業。
Hansoh Pharmaceutical Group Company Limited 何時完成拆股?▼
Hansoh Pharmaceutical Group Company Limited 最近沒有進行任何拆股。
Hansoh Pharmaceutical Group Company Limited 的總部在哪裡?▼
Hansoh Pharmaceutical Group Company Limited 的總部位於 開曼群島 的 Shanghai。